After $10.9B exit to AbbVie, Apogee execs join Paragon to scale its R&D, company creation engine
Apogee execs join Paragon after AbbVie buyout to scale R&D and company creation engine
5 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 5 separate news trends connected to R&D, spanning July 28, 2026 through October 13, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 46 article observations and 45 source signals, led by Business coverage. Use it to compare how individual events emerged, spread and changed over time.
Apogee execs join Paragon after AbbVie buyout to scale R&D and company creation engine
AstraZeneca pours over $1 billion into a new Cambridge R&D hub, saying it won’t need deals to grow past 2030.
Sanofi pays Regeneron $1B upfront for 4 early-stage assets to expand immunology alliance
Takeda announces Andy Plump’s June 2027 retirement after steering back‑to‑back approvals and a major pipeline overhaul.
GSK’s July 28 earnings beat powers a $2.5 billion three‑year savings drive and an Arizona HQ shift to fast‑track its drug pipeline.